ArticleJournal of orthopaedic translation2021

Tyloxapol inhibits RANKL-stimulated osteoclastogenesis and ovariectomized-induced bone loss by restraining NF-κB and MAPK activation.

Wen Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.